eISSN: 2450-5722
ISSN: 2450-5927
Journal of Health Inequalities
Current issue Archive Online first About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
1/2019
vol. 5
 
Share:
Share:
abstract:

The future of treatment of tobacco dependence – harnessing technology to deliver hybrid interventions

Aleksandra Herbeć
1, 2

1.
Health Promotion Foundation, Nadarzyn, Poland
2.
Centre for Behaviour Change, Clinical Educational, and Health Psychology, UCL, London, UK
J Health Inequal 2019; 5 (1): 49
Online publish date: 2019/07/31
View full text Get citation
 
PlumX metrics:
Over the past decades many high-income countries have witnessed marked declines in the prevalence of smoking among adults and children. This success could be attributed to several factors, including evidence-based tobacco control programmes, as well as supranational initiatives and grassroots movements, energised by the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC). Nonetheless, 1 billion people globally continue to smoke. While the majority of smokers want to quit and make frequent attempts to do so, stronger strategies are needed to increase abstinence rates.
There has been a growing offer in terms of on-prescription and over-the-counter pharmacotherapy supporting smoking cessation. More recently we have seen the emergence of next-generation diverse nicotine-delivery devices that might aid cessation, at least among some smokers. In countries like Poland we have also observed a rekindled interest among smokers in pharmacological support, which could at least partially be attributed to vigorous marketing and promotional campaigns, especially on television. Indeed, around one million packages of cessation medications were sold in Poland in 2014 and 2015, primary of cytisine-based drugs.
However, there are important limitations to the many cessation programmes. First of all, access to affordable and evidence-based cessation support is very limited in many countries, and only a small minority of smokers in Europe access such support. Secondly, adherence to both behavioural as well as pharmacological support is low, which is likely to hinder success.
Digital interventions have long held promise to offset some of the limitations of traditional cessation support, including to extend the reach of cessation programmes. We have evidence that many forms of self-help interventions can aid cessation, including printed materials, mobile-based support (e.g. SMS texting), as well as computer- and Internet-based support. More recently, interest has shifted towards smartphone-based programmes for quitting smoking that offer ever more diverse opportunities to intervene, collect data, and personalise the support offered. However, evidence on their effectiveness remains scarce, which is also due to the challenges of conducting well controlled studies in this field. Moreover, technologically-supported cessation programmes face two key challenges: low uptake among the general population, and high attrition and low engagement...


View full text...
keywords:

cigarette smoking, digital health, healthcare system


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.